Cueto-Manzano A M, Quintana-Piña E, Correa-Rotter R
Unidad de Investigación Médica en Epidemiología Clinica, Hospital de Especialidades, CMNO, IMSS, Guadalajara, Jalisco, Mexico.
Perit Dial Int. 2001 Mar-Apr;21(2):148-53.
To evaluate patient and technique survival, and to analyze mortality risk factors in a large Mexican single-center continuous ambulatory peritoneal dialysis (CAPD) program.
Cohort study.
Tertiary care, teaching hospital located in Mexico City.
All patients from our CAPD program (1985-1997) were retrospectively studied.
Clinical and biochemical variables at the start of dialysis were recorded and considered in the analysis of risk factors.
End points were patient (alive, dead, or lost to follow-up) and technique status at the end of the study (December 1997).
627 patients, 37% with diabetes mellitus (DM), were included. Median patient survival (+/- SE) was 5.1 +/- 0.6 years. In the univariate analysis, the following variables were associated (p < 0.05) with mortality: DM, old age, hypoalbuminemia, low serum creatinine, low serum phosphate, and lymphopenia. In the multivariate analysis, the only significant mortality risk factors were DM (RR 2.56, p < 0.0001), old age (RR 1.01, p = 0.01), hypoalbuminemia (RR 0.77, p = 0.04), and lymphopenia (RR 0.98, p = 0.05). Median technique survival was 4.0 +/- 0.2 years. Peritonitis, hypoalbuminemia, lymphopenia, old age, and DM were all significantly associated (p < 0.05) with technique failure in the univariate analysis, while in the multivariate analysis, only DM (RR 1.78, p = 0.001), peritonitis (RR 1.13, p = 0.004), lymphopenia (0.98, p = 0.04), and hypoalbuminemia (RR 0.80, p = 0.06) were technique failure predictors.
Patient survival in our setting is similar to that reported in other series. Diabetes mellitus, lymphopenia, and hypoalbuminemia were the strongest predictive factors for mortality and technique failure on CAPD. Our 12-year CAPD program is one of the largest single-centers reported in CAPD literature.
评估患者生存率和技术生存率,并分析墨西哥一个大型单中心持续性非卧床腹膜透析(CAPD)项目中的死亡风险因素。
队列研究。
位于墨西哥城的三级护理教学医院。
对我们CAPD项目(1985 - 1997年)的所有患者进行回顾性研究。
记录透析开始时的临床和生化变量,并在风险因素分析中予以考虑。
终点为研究结束时(1997年12月)的患者状态(存活、死亡或失访)和技术状态。
纳入627例患者,其中37%患有糖尿病(DM)。患者中位生存时间(±标准误)为5.1±0.6年。单因素分析中,以下变量与死亡率相关(p<0.05):糖尿病、老年、低白蛋白血症、低血清肌酐、低血清磷酸盐和淋巴细胞减少。多因素分析中,唯一显著的死亡风险因素为糖尿病(相对危险度RR 2.56,p<0.0001)、老年(RR 1.01,p = 0.01)、低白蛋白血症(RR 0.77,p = 0.04)和淋巴细胞减少(RR 0.98,p = 0.05)。技术中位生存时间为4.0±0.2年。单因素分析中,腹膜炎、低白蛋白血症、淋巴细胞减少、老年和糖尿病均与技术失败显著相关(p<